维普期刊资源整合服务平台（V6.5）

107篇 您的检索式：作者名="Semiglazov V"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Neoadjuvantand adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with aparallel HER2-negative cohort显示文摘	Gianni L Eiermann W Semiglazov V eral	2014	Lancet Oncol2014，15，6：	1
2	Neoadjuvant and adjuvant trastuzumab in patients with HER-2-positive locally ad- vanced breast cancer (NOAH) : follow-up of a randomised con- trolled superiority trial with a parallel HER-2-negative cohort显示文摘	Gianni L Eiermann W Semiglazov V	2014	Lancet Oncol2014，15，6：	1
3	Phase Ⅱ randomizedstudyofneoadjuvanteverolimusplusletrozolecomparedwithplaceboplusletrozoleinpatientswithestrogenreceptorposi-tivebreastcancer显示文摘	BaselgaJ Semiglazov V van Dam P	2009	JClinOncol2009，27，11：	1
4	Phase II randomized study of neoadjuvant everolimus plus letrozole compared with pla- cebo plus letrozole in patients with estrogen receptor - positive breast cancer 显示文摘	Baselga J Semiglazov V Van Dam P	2009	J Clin Oncol2009，27，16：	1
5	Phase II randomized study of neoadjuvant everolimus plus letro- zole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer显示文摘	Baselga J Semiglazov V van Dam P	2009	J Clin Oncol2009，27，16：	1
6	Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone,in patients with HER2-positive locally advanced breast cancer(the NOAH trial):a randomised controlled superiority trial with a parallel HER2-negative cohort显示文摘	Gianni L Eiermann W Semiglazov V	2010	Lancet2010，375，9712：	1
7	Exemestane vs tamoxifen as neoadjuvant endocrine therapy for post-menopausal women with ER + breast cancer (T2NI-2, T3N0I, T4NOM0) 显示文摘	Semiglazov V Kletsel A Semiglazov V	2005	J Clin Oncol2005，23，16：	1
8	Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone,in patients with HER2-positive locally advanced breast cancer (the NOAH trial):a randomised controlled superiority trial with a parallel HER2-显示文摘	Gianni L Eiermann W Semiglazov V		0，，9712：	1
9	Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor- positive breast cancer显示文摘	Baselga J Semiglazov V van Dam P	2009	J Clin Oncol2009，27，16：	1
10	Neoadjuvant and ad- juvant trastuzumab in patients with ER2-positive locally advanced breast cancer(NOAH) : follow-up of a randomised controlled supe- riority trial with a parallel HER2-negative cohort 显示文摘	Gianni L Eiermann W Semiglazov V	2014	Lancet On- col2014，15，6：	1
11	Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone,in patients with HER2-positive locally advanced breast cancer(the NOAH trial):a randomised controlled superiority trial with a parallel HER2-negative cohort显示文摘	Gianni L Eiermann W Semiglazov V	2010	Lancet2010，375，9712：	1
12	Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone,in patients with HER2-positive locally advanced breast cancer(the NOAH trial):a randomised controlled superiority trial with a parallel HER2-negative cohort显示文摘	Gianni L Eiermann W Semiglazov V	2010	Lancet2010，375，：	1
13	Surgery following neoadjuvant therapy in patients with Her-2-positive locally advanced or inflammatory breast cancer participating in the Neoadjuvant Herceptin (NOAH) study显示文摘	Semiglazov V Eiermann W Zambetti M		0，，10：	1
14	Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study显示文摘	Leyland-Jones B Semiglazov V Pawlicki M	2005	J Clin Oncol2005，23，：	1
15	Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer显示文摘	Baselga J Semiglazov V van Dam P	2009	J Clin Oncol2009，27，16：	1
16	Phase Ⅱ randomized study of neoadjuvant EverolJmus plus Letrozole compared with placebo plus Letrozole in patients with estrogen receptor-positive breast cancer 显示文摘	Baselga J Semiglazov V van Dam P	2009	J Clin Oncol2009，27，16：	1
17	Maintaining normal hemoglobin levels with epoetin a in mainly nonanemic patients with metastatic breast cancer receiving first2line chemotherapy:a survival study显示文摘	Leyland2Jones B Semiglazov V Pawlicki M		0，，：	1
18	Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemicpatients with metastatic breast cancer receiving first-line chemotherapy:a survival study显示文摘	Leyland-Jones B Semiglazov V Pawlicki M	2005	J Clin Oncol2005，23，25：	1
19	Maintaining normal hemoglobin levels with epoetin alia in mainly nonanemie patients with metastatic breast cancer receiving first-line chemo- therapy : A survival study 显示文摘	Leyand-Jones B Semiglazov V Pawlicki M	2005	J Clin Oncol2005，23，25：	1
20	Effects of fulvestrant 250 mg in premenopausal women with oestrogen receptor-positive primary breast cancer 显示文摘	Robertson JF Semiglazov V Nemsadze G	2007	Eur J Cancer2007，43，1：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示